Information  X 
Enter a valid email address

Company Name matching 'Tiziana Life Sciences Plc'

Date
Time Source
Company
Announcement
25 Sep 2020 7:00 am GNW   Tiziana Life Sciences Plc Tiziana Life Sciences Interview to Air on Bloomberg International on The RedChip Money Report
21 Sep 2020 2:51 pm GNW   Tiziana Life Sciences Plc Tiziana Life Sciences plc: Publication of Research Note
17 Sep 2020 7:00 am GNW   Tiziana Life Sciences Plc Tiziana Life Sciences plc to Conduct a Clinical Study with Nasally Administered Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody, for Treatment of COVID-19 Patients in Brazil
16 Sep 2020 7:00 am GNW   Tiziana Life Sciences Plc Tiziana Life Sciences Plc ("Tiziana" or the "Company") - Demerger of StemPrintER and Distribution in Specie
28 Aug 2020 10:30 am GNW   Tiziana Life Sciences Plc Tiziana Life Sciences Clarifies Reason for Filing an Amended ADS Registration Statement
27 Aug 2020 7:00 am GNW   Tiziana Life Sciences Plc Tiziana Life Sciences CEO Updates Shareholders on its Patent Portfolio, Clinical Pipeline, and Strategy in an Exclusive Interview
24 Aug 2020 7:00 am GNW   Tiziana Life Sciences Plc Tiziana Granted a Patent on Methods and Use of Anti-IL-6/IL-6 receptor Monoclonal Antibodies as Prophylactic and Therapeutic Interventions for COVID-19 and other pulmonary diseases
21 Aug 2020 7:00 am GNW   Tiziana Life Sciences Plc Tiziana Granted a Patent on the Use of Milciclib in Combination with Tyrosine Kinase Inhibitors for Treatment of Hepatocellular Carcinoma and other Cancers
20 Aug 2020 7:00 am GNW   Tiziana Life Sciences Plc Tiziana is Pleased to Retain Dr. Napoleone Ferrara to Serve on Its Scientific Advisory Board for an Additional Three-Year Term
18 Aug 2020 7:00 am GNW   Tiziana Life Sciences Plc Tiziana Granted a Patent on Methods and Use of Anti-CD3 Monoclonal Antibodies for Treatment of Crohn’s Disease
11 Aug 2020 9:00 am GNW   Tiziana Life Sciences Plc Tiziana Life Sciences to Present at BTIG’s Virtual Biotechnology Conference
05 Aug 2020 4:00 pm GNW   Tiziana Life Sciences Plc Tiziana Life Sciences plc Announces Closing of $57.25 Million Offering
04 Aug 2020 7:00 am GNW   Tiziana Life Sciences Plc Tiziana Life Sciences Announces an Expedited Clinical Development Plan for Its Anti-Interleukin-6-Receptor, a Fully Human Monoclonal Antibody, for the Treatment of COVID-19 Patients
03 Aug 2020 7:00 am GNW   Tiziana Life Sciences Plc Tiziana Announces Pricing of U.S. Follow-On Offering of ADSs Raising $57.25 million
31 Jul 2020 5:00 pm GNW   Tiziana Life Sciences Plc Tiziana Life Sciences plc: Total Voting Rights
  7:00 am GNW   Tiziana Life Sciences Plc Tiziana Life Sciences plc: Tiziana Announces Submission of a Patent Application for Nasal Administration of Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody, for Treatment of COVID-19 Patients
30 Jul 2020 4:31 pm GNW   Tiziana Life Sciences Plc Tiziana Life Sciences plc: Early notification of proposed admission to the Official List and cancellation of trading on AIM
  7:00 am GNW   Tiziana Life Sciences Plc Tiziana Life Sciences to Participate in Investor Webinar to Provide Corporate Updates and Q&A Session on July 30, 2020
24 Jul 2020 7:00 am GNW   Tiziana Life Sciences Plc Exercise of Warrants and Issue of Equity and Total Voting Rights
20 Jul 2020 3:17 pm GNW   Tiziana Life Sciences Plc Tiziana Life Sciences plc ("Tiziana" or the "Company") Director Appointment
16 Jul 2020 12:23 pm GNW   Tiziana Life Sciences Plc Results of Annual General Meeting
  7:00 am GNW   Tiziana Life Sciences Plc Tiziana Announces Submission of Patent Application on Use of Foralumab, the Only Fully Human Anti-CD3 Monoclonal Antibody, to Enhance Success of CAR-T Therapy
15 Jul 2020 4:56 pm GNW   Tiziana Life Sciences Plc Tiziana Life Sciences plc Change to ADS Ratio - Updated
  1:28 pm GNW   Tiziana Life Sciences Plc Tiziana Life Sciences plc Change to ADS Ratio
10 Jul 2020 6:41 pm GNW   Tiziana Life Sciences Plc Tiziana Life Sciences Interview to Air on Bloomberg International on the RedChip Money Report
18 Jun 2020 6:50 pm GNW   Tiziana Life Sciences Plc Tiziana Life Sciences PLC Directorate Change
20 Mar 2019 7:00 am GNW   Tiziana Life Sciences Plc Tiziana Submits IND Application for Oral Formulation of Foralumab for Treatment of NASH
30 Sep 2014 7:00 am GNW Factsheet Tiziana Life Sciences PLC (TILS) Interim Results for the Six Months Ended 30 Jun...
12 Sep 2014 7:00 am GNW Factsheet Tiziana Life Sciences PLC (TILS) Scientific Advisory Board Appointment
05 Sep 2014 4:22 pm GNW Factsheet Tiziana Life Sciences PLC (TILS) Realisation bonuses
31 Jul 2014 2:41 pm GNW Factsheet Tiziana Life Sciences PLC (TILS) EXERCISE OF OPTIONS AND ISSUE OF EQUITY
03 Jul 2014 12:02 pm GNW Factsheet Tiziana Life Sciences PLC (TILS) Grant of Options
30 Jun 2014 7:02 am GNW Factsheet Tiziana Life Sciences PLC (TILS) Licensing agreement to develop stem cell based ...
25 Jun 2014 12:27 pm GNW Factsheet Tiziana Life Sciences PLC (TILS) Tiziana Life Sciences PLC : Result of AGM
20 Jun 2014 3:57 pm GNW Factsheet Tiziana Life Sciences PLC (TILS) Exercise of Options & Issue of Equity
17 Jun 2014 7:00 am GNW Factsheet Tiziana Life Sciences PLC (TILS) Issue of Convertible Loan Notes and Warrants
23 May 2014 1:35 pm GNW Factsheet Tiziana Life Sciences PLC (TILS) Notice of AGM
19 May 2014 7:01 am GNW Factsheet Tiziana Life Sciences PLC (TILS) Scientific Advisory Board Appointment
24 Apr 2014 11:15 am GNW Factsheet Tiziana Life Sciences PLC (TILS) First Day of Dealings


Company Announcements Archive »

 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t